221 related articles for article (PubMed ID: 32314663)
1. Robust Optimization of SBRT Planning for Patients With Early Stage Non-Small Cell Lung Cancer.
Shang H; Pu Y; Wang Y
Technol Cancer Res Treat; 2020; 19():1533033820916505. PubMed ID: 32314663
[TBL] [Abstract][Full Text] [Related]
2. Technical Note: Dosimetric evaluation of Monte Carlo algorithm in iPlan for stereotactic ablative body radiotherapy (SABR) for lung cancer patients using RTOG 0813 parameters.
Pokhrel D; Badkul R; Jiang H; Kumar P; Wang F
J Appl Clin Med Phys; 2015 Jan; 16(1):5058. PubMed ID: 25679161
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric comparison of four-dimensional computed tomography based internal target volume against variations in respiratory motion during treatment between volumetric modulated arc therapy and three-dimensional conformal radiotherapy in lung stereotactic body radiotherapy.
Fujimoto D; Takatsu J; Hara N; Oshima M; Tomihara J; Segawa E; Inoue T; Shikama N
Radiol Phys Technol; 2024 Mar; 17(1):143-152. PubMed ID: 37930563
[TBL] [Abstract][Full Text] [Related]
4. Normal lung sparing Tomotherapy technique in stage III lung cancer.
Hong CS; Ju SG; Ahn YC; Yoo GS; Noh JM; Oh D; Chung K; Pyo H; Jo K
Radiat Oncol; 2017 Nov; 12(1):167. PubMed ID: 29110732
[TBL] [Abstract][Full Text] [Related]
5. The irregular breathing effect on target volume and coverage for lung stereotactic body radiotherapy.
Pan CH; Shiau AC; Li KC; Hsu SH; Liang JA
J Appl Clin Med Phys; 2019 Jul; 20(7):109-120. PubMed ID: 31207034
[TBL] [Abstract][Full Text] [Related]
6. Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer.
Register SP; Zhang X; Mohan R; Chang JY
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1015-22. PubMed ID: 20615629
[TBL] [Abstract][Full Text] [Related]
7. Effects of respiratory motion on passively scattered proton therapy versus intensity modulated photon therapy for stage III lung cancer: are proton plans more sensitive to breathing motion?
Matney J; Park PC; Bluett J; Chen YP; Liu W; Court LE; Liao Z; Li H; Mohan R
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):576-82. PubMed ID: 24074932
[TBL] [Abstract][Full Text] [Related]
8. Optimizing the prescription isodose level in stereotactic volumetric-modulated arc radiotherapy of lung lesions as a potential for dose de-escalation.
Chan M; Wong M; Leung R; Cheung S; Blanck O
Radiat Oncol; 2018 Feb; 13(1):24. PubMed ID: 29426358
[TBL] [Abstract][Full Text] [Related]
9. Quantifying the Effect of 4-Dimensional Computed Tomography-Based Deformable Dose Accumulation on Representing Radiation Damage for Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Standard-Fractionated Intensity-Modulated Radiation Therapy.
He Y; Cazoulat G; Wu C; Svensson S; Almodovar-Abreu L; Rigaud B; McCollum E; Peterson C; Wooten Z; Rhee DJ; Balter P; Pollard-Larkin J; Cardenas C; Court L; Liao Z; Mohan R; Brock K
Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):231-241. PubMed ID: 37552151
[TBL] [Abstract][Full Text] [Related]
10. Impact of robust treatment planning on single- and multi-field optimized plans for proton beam therapy of unilateral head and neck target volumes.
Cubillos-Mesías M; Baumann M; Troost EGC; Lohaus F; Löck S; Richter C; Stützer K
Radiat Oncol; 2017 Nov; 12(1):190. PubMed ID: 29183377
[TBL] [Abstract][Full Text] [Related]
11. Automation and integration of a novel restricted single-isocenter stereotactic body radiotherapy (a-RESIST) method for synchronous two lung lesions.
Critchfield LS; Visak J; Bernard ME; Randall ME; McGarry RC; Pokhrel D
J Appl Clin Med Phys; 2021 Jul; 22(7):56-65. PubMed ID: 34032380
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric evaluation in Helical TomoTherapy for lung SBRT using Monte Carlo-based independent dose verification software.
Kosaka T; Takatsu J; Inoue T; Iijima K; Suzuki M; Murakami N; Shikama N
J Appl Clin Med Phys; 2024 May; 25(5):e14305. PubMed ID: 38368607
[TBL] [Abstract][Full Text] [Related]
13. An uncertainty-incorporated method for fast beam angle selection in intensity-modulated proton therapy.
Ramar N; Meher SR
J Cancer Res Ther; 2023; 19(3):688-696. PubMed ID: 37470595
[TBL] [Abstract][Full Text] [Related]
14. Quantification of plan robustness against different uncertainty sources for classical and anatomical robust optimized treatment plans in head and neck cancer proton therapy.
Cubillos-Mesías M; Troost EGC; Lohaus F; Agolli L; Rehm M; Richter C; Stützer K
Br J Radiol; 2020 Mar; 93(1107):20190573. PubMed ID: 31778315
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two optimization algorithms (VOLO
Thiele M; Galonske K; Ernst I
J Appl Clin Med Phys; 2023 Dec; 24(12):e14144. PubMed ID: 37672349
[TBL] [Abstract][Full Text] [Related]
16. Evaluating which plan quality metrics are appropriate for use in lung SBRT.
Yaparpalvi R; Garg MK; Shen J; Bodner WR; Mynampati DK; Gafar A; Kuo HC; Basavatia AK; Ohri N; Hong LX; Kalnicki S; Tome WA
Br J Radiol; 2018 Feb; 91(1083):20170393. PubMed ID: 29227151
[TBL] [Abstract][Full Text] [Related]
17. On the optimal number of dose-limiting shells in the SBRT auto-planning design for peripheral lung cancer.
Duan Y; Gan W; Wang H; Chen H; Gu H; Shao Y; Feng A; Ying Y; Fu X; Zhang C; Xu Z; Jeff Yue N
J Appl Clin Med Phys; 2020 Sep; 21(9):134-142. PubMed ID: 32700823
[TBL] [Abstract][Full Text] [Related]
18. Treatment plan quality during online adaptive re-planning.
van Timmeren JE; Chamberlain M; Krayenbuehl J; Wilke L; Ehrbar S; Bogowicz M; Hartley C; Zamburlini M; Andratschke N; Garcia Schüler H; Pavic M; Balermpas P; Ryu C; Guckenberger M; Tanadini-Lang S
Radiat Oncol; 2020 Aug; 15(1):203. PubMed ID: 32825848
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Photon Intensity Modulated Radiation Therapy Robustness in Patients With Prostate Cancer as a Proposed Benchmark for Proton Therapy Robustness Evaluation.
Maas JA; McDonald AM; Cardan RA; Snider JW; Fiveash JB; Kole AJ
Pract Radiat Oncol; 2024; 14(1):e68-e74. PubMed ID: 37748679
[TBL] [Abstract][Full Text] [Related]
20. Optimising stereotactic body radiotherapy for non-small cell lung cancer with volumetric intensity-modulated arc therapy--a planning study.
Brock J; Bedford J; Partridge M; McDonald F; Ashley S; McNair HA; Brada M
Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):68-75. PubMed ID: 21396808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
